SANFORD BEMIDJI
1. Target Overview & Investment Thesis
SANFORD BEMIDJI is a 94-bed safety-net/medicaid heavy in BELTRAMI, MN with $312.6M in net patient revenue and a -19.6% operating margin. The hospital serves a payer mix of 36.3% Medicare, 28.0% Medicaid, and 35.7% commercial.
Thesis: Turnaround. Our ML models identify $23.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -19.6% to -12.3% (+736bps).
| Net Revenue HCRIS | $312.6M |
| Current EBITDA COMPUTED | $-61.4M |
| Operating Margin COMPUTED | -19.6% |
| Occupancy HCRIS | 57.8% |
| Revenue / Bed COMPUTED | $3.3M |
| Net-to-Gross HCRIS | 38.7% |
| Distress Probability ML | 50.5% |
2. Market Context & Competitive Position
MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -19.6% places it below the state median. Among 23 size-comparable peers (47-188 beds), the median margin is -5.9%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (47-188), prioritizing same-state peers. 23 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SANFORD BEMIDJI (Target) | MN | 94 | $312.6M | -19.6% |
| SMDC MEDICAL CENTER | MN | 118 | $519.2M | -7.1% |
| MCHS - SOUTHWEST MINNESOTA REG | MN | 118 | $473.6M | -9.8% |
| LAKEVIEW MEMORIAL | MN | 68 | $411.9M | 60.9% |
| HEALTHEAST ST JOHNS HOSPITAL | MN | 184 | $375.8M | -7.7% |
| FAIRVIEW RIDGES HOSPITAL | MN | 172 | $316.2M | 7.0% |
| RIDGEVIEW MEDICAL CENTER | MN | 109 | $287.8M | -14.2% |
| ST. JOSEPHS MEDICAL CENTER | MN | 127 | $283.3M | -0.0% |
| MAYO CLNIC HLTH SYS-ALBRT LEA | MN | 79 | $271.9M | -16.6% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $23.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $6.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $6.3M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $6.2M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $3.8M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $200K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-61.4M |
| + RCM Uplift | +$23.0M |
| Pro Forma EBITDA | $-38.4M |
| Current Margin | -19.6% |
| Pro Forma Margin | -12.3% |
| WC Released (1x) | $12.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-94.4M | $-174.8M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-94.4M | $-222.9M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-85.0M | $-177.6M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-85.0M | $-218.9M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-103.9M | $-259.1M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-103.9M | $-318.8M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (28.0%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 50.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 23 hospitals with 47-188 beds
- Same-state prioritization (n=24)
- Comp margins: P25=-9.2% / P50=-5.9% / P75=-0.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.